ALGIPHARMA HOLDING AS

Operating

Investere i andre selskap som driver forskning og kommersialisering av forskningsprosjekter og forskningsresultater knyttet til alginater og annen bioteknologi og virksomhet i tilknytning til dette.

Organization

Chairman of the board: YP
Yngvar Peter Berg1962
Years since formation: 9 years; since Dec 29, 2017
Type: Limited company
VAT registered: No
Number of employees: 0

Ownership

Number of shares and share classes: 11,359,171; 1 share class
Total number of shareholders: 47; 17 companies, 30 persons
Belongs to group of

Financials

Annual total result 2025: -4,528,550; NOK

Last update: Jul 25, 2026

Management

Board

Name	Role	Shares
YP Yngvar Peter Berg 1962	Chairman	-
AD Arne Dessen 1959	Board Member	-
DB Diderik Børsting Schnitler 1946	Board Member	-
CA Charles Anthony Cowper Johnson 1950	Board Member	-
MJ Michael Jeffrey Walters 1959	Board Member	-
PW Preston White Campbell Iii 1953	Board Member	-
JN John Nicholas Ralph Wilkinson 1964	Board Member	-

Others

Name	Role	Shares
C CEDRA NORGE AS	Auditor	-

Top 10 individual shareholders

Name	Role	Shares
PB Peter Berg Yngvar 1962	-	83.03 % indirectly
AB Alexander Berg Christian 1967	-	8.46 % indirectly
DA Dessen Arne 1959	-	1.17 % indirectly

Last update: Dec 9, 2025

Ownership

Company shareholders

Name	Share class	Total number of shares	Share
D DRAMMEN SLIP & VERKSTED AS	Ordinary shares	9,396,639	82.72 %
M MARCHMAIN AS	Ordinary shares	961,048	8.46 %
R ROQUETTE NORWAY AS	Ordinary shares	175,000	1.54 %
S STIFTELSEN BIOPOLYMER	Ordinary shares	175,000	1.54 %
D DESSEN INVEST AS	Ordinary shares	132,478	1.17 %
L LØKTA AS	Ordinary shares	126,539	1.11 %
O ONSØYEN INVEST AS	Ordinary shares	39,346	0.35 %
F Frydenberg AS	Ordinary shares	34,409	0.3 %
Y YM-MEDICAL AS	Ordinary shares	25,000	0.22 %
JW Jeffrey Walters Michael	Ordinary shares	21,000	0.18 %
WJ Wilkinson John	Ordinary shares	21,000	0.18 %
AC Anthony Cowper Johnson Charles	Ordinary shares	21,000	0.18 %
O ONEDOC AS	Ordinary shares	19,019	0.17 %
RW Richard Wicks Stephen	Ordinary shares	13,500	0.12 %
GT Gmbh Transformrx	Ordinary shares	13,500	0.12 %
F FAGERBAKK AS	Ordinary shares	13,275	0.12 %
KI Kreutzer Idar 1962	Ordinary shares	12,750	0.11 %
HA Herstrøm Arve 1946	Ordinary shares	12,074	0.11 %
SJ Sleboda Jowita 1970	Ordinary shares	10,000	0.09 %
KA Kristiansen Are 1965	Ordinary shares	8,528	0.08 %
MH Morris Hilde 1957	Ordinary shares	8,000	0.07 %
FH Foros Hilde 1975	Ordinary shares	7,000	0.06 %
R RB PHARMA AS	Ordinary shares	7,000	0.06 %
KM Kaniusaite Milda 1987	Ordinary shares	7,000	0.06 %
DR Desmond Rye Philip 1962	Ordinary shares	5,000	0.04 %
RM Ragnar Meling Torstein 1968	Ordinary shares	3,656	0.03 %
GS Gudmund Skjåk-Bræk Ola 1946	Ordinary shares	3,581	0.03 %
AS Aasmund Smidsrød Olav 1936	Ordinary shares	3,081	0.03 %
EF Edin Flaten Hugo 1950	Ordinary shares	3,000	0.03 %
EN Einar Nilsen Per 1966	Ordinary shares	3,000	0.03 %
O OLE T FEVANG AS	Ordinary shares	3,000	0.03 %
HS Haukland Siv 1966	Ordinary shares	3,000	0.03 %
KW Karine Wang Haflan Anne 1962	Ordinary shares	3,000	0.03 %
BJ Bjørn Jacobsen Ole 1956	Ordinary shares	3,000	0.03 %
CA Charles Austin Martin	Ordinary shares	2,948	0.03 %
S SURVIVA AS	Ordinary shares	2,626	0.02 %
HL Heggelund Lars 1966	Ordinary shares	2,437	0.02 %
H HEICO INVEST AS	Ordinary shares	2,436	0.02 %
DT D Tovey Geoffrey	Ordinary shares	2,000	0.02 %
ET Espevik Terje 1954	Ordinary shares	1,883	0.02 %
MG Mosekjær Graver Anne 1984	Ordinary shares	1,500	< 0.01 %
ID Ingar Draget Kurt 1958	Ordinary shares	1,300	< 0.01 %
N NEWPORT INVEST AS	Ordinary shares	1,218	< 0.01 %
KO Koppervik Ola 1963	Ordinary shares	1,000	< 0.01 %
S SYNOVIA AS	Ordinary shares	1,000	< 0.01 %
SI Smiljanic Ivana 1982	Ordinary shares	1,000	< 0.01 %
TN Taylor Nordgård Catherine 1977	Ordinary shares	900	< 0.01 %

Shares owned by the ALGIPHARMA HOLDING AS

Name	Share class	Total number of shares	Share
A ALGIPHARMA AS	Ordinary shares	11,278,404	100 %

Last update: Sep 25, 2026

Group structure

Frydenberg AS
Total operating income 2025: NOK 0
Operating profit 2025: NOK -91,189
Employees: 0

Financials

in NOK

Summary

Year	2025	2024	2023	2022	2021
Total operating income	0	0	0	0	0
Annual Total Result	-4,528,550	-579,664	-962,799	-52,157	0
Total assets	0	202,968,626	175,918,790	143,621,451	15,000
Total liabilities	0	2,547,274	52,614,484	59,354,340	15,000
Total equity	0	200,421,352	123,304,306	84,267,110	0

P&L

Year	2025	2024	2023	2022
Total operating income	0	0	0	0
Total operating costs	4,474,629	198,906	158,363	52,157
Operating result	-4,474,629	-198,906	-158,363	-52,157
Financial income/costs	-53,922	-380,758	-688,667	0
Profit before tax	-4,528,550	-579,664	-847,030	-52,157
Total tax & extraordinary income/cost	0	0	115,769	0
Annual Total Result	-4,528,550	-579,664	-962,799	-52,157

Balance overview

Year	2024	2023	2022	2021
Total fixed assets	201,254,755	144,734,725	93,606,453	0
Total current assets	1,713,871	31,184,066	50,014,998	15,000
Total assets	202,968,626	175,918,790	143,621,451	15,000
Short term debt	0	680,999	67,157	15,000
Long term debt	2,547,274	51,933,485	59,287,183	0
Total liabilities	2,547,274	52,614,484	59,354,340	15,000
Contributed capital	201,001,016	123,304,306	84,319,268	0
Retained earnings	-579,664	0	-52,157	0
Total equity	200,421,352	123,304,306	84,267,110	0
Total equity and liabilities	202,968,626	175,918,790	143,621,451	15,000

Classification

21st company classification

BETA

Small company

Type of organization

Limited company

Classification of institutional sector

INNL

Domestic sectors

A_IKKE-FIN

Non-financial corporations

2100

Private non-financial incorporated enterprises

Standard industrial classification

ALGIPHARMA HOLDING AS920 171 591